| Line Item | 2024-02-02 | Y/Y |
|---|---|---|
| Revenue | $365.9M | -21.1% |
| Cost of Revenue | $148.1M | -22.7% |
| Gross Profit | $217.8M | -19.9% |
| R&D Expense | $111.0M | -21.7% |
| SG&A Expense | $83.2M | -25.4% |
| Operating Income | -$112.0M | +24.4% |
| Pre-tax Income | -$114.5M | +22.0% |
| Income Tax | -$28.5M | +11.8% |
| Net Income | -$86.0M | +24.9% |
| EPS (Basic) | -$1.00 | +26.5% |
| EPS (Diluted) | -$1.00 | +26.5% |
| Line Item | 2024-02-02 | Y/Y |
|---|---|---|
| Cash & Equivalents | $68.7M | -52.2% |
| Accounts Receivable | $54.3M | -25.3% |
| Inventory | $727K | +17.3% |
| Current Assets | $138.1M | -41.0% |
| Total Assets | $724.8M | -13.8% |
| Current Liabilities | $202.1M | -17.7% |
| Total Liabilities | $223.5M | -21.0% |
| Line Item | 2024-02-02 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$59.2M | +5.5% |
| Capital Expenditures | $1.2M | -39.4% |
| Investing Cash Flow | -$6.4M | -13.7% |
| Financing Cash Flow | -$6.2M | +30.7% |
| Free Cash Flow | -$60.3M | +6.5% |
| Stockholders' Equity |
| $501.3M |
| -10.2% |